Michele Graciotti

968 total citations
16 papers, 463 citations indexed

About

Michele Graciotti is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Michele Graciotti has authored 16 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 10 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Michele Graciotti's work include Immunotherapy and Immune Responses (12 papers), Cancer Immunotherapy and Biomarkers (8 papers) and vaccines and immunoinformatics approaches (4 papers). Michele Graciotti is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), Cancer Immunotherapy and Biomarkers (8 papers) and vaccines and immunoinformatics approaches (4 papers). Michele Graciotti collaborates with scholars based in Switzerland, Italy and United States. Michele Graciotti's co-authors include Lana E. Kandalaft, Michal Bassani‐Sternberg, Alexandre Harari, Ernesto Di Mauro, Veronica Neri, Giovanna Costanzo, Claudia Crestini, Raffaele Saladino, Ananda Mookerjee and Cristiana Berti and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Nature Reviews Drug Discovery.

In The Last Decade

Michele Graciotti

16 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michele Graciotti Switzerland 11 272 207 172 98 70 16 463
Nuria Sánchez‐Puig Mexico 14 178 0.7× 404 2.0× 92 0.5× 33 0.3× 18 0.3× 30 777
Hyunsung John Kim United States 7 58 0.2× 291 1.4× 64 0.4× 98 1.0× 42 0.6× 7 457
Jianjian Guo China 7 108 0.4× 204 1.0× 177 1.0× 119 1.2× 44 0.6× 8 460
Gerald Haaima Denmark 14 110 0.4× 912 4.4× 38 0.2× 58 0.6× 18 0.3× 21 1.1k
Terry L. Sheppard United States 16 32 0.1× 910 4.4× 174 1.0× 36 0.4× 17 0.2× 36 1.1k
Keyong Zou United States 9 79 0.3× 437 2.1× 29 0.2× 25 0.3× 30 0.4× 9 582
Sarah Earley United States 9 21 0.1× 182 0.9× 79 0.5× 79 0.8× 9 0.1× 9 380
Hiroaki Takahashi Japan 9 204 0.8× 446 2.2× 76 0.4× 38 0.4× 21 0.3× 26 634
John Haugner United States 7 138 0.5× 239 1.2× 190 1.1× 13 0.1× 5 0.1× 7 383
Matteo Allegretti Italy 12 22 0.1× 423 2.0× 58 0.3× 91 0.9× 39 0.6× 27 616

Countries citing papers authored by Michele Graciotti

Since Specialization
Citations

This map shows the geographic impact of Michele Graciotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Graciotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Graciotti more than expected).

Fields of papers citing papers by Michele Graciotti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Graciotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Graciotti. The network helps show where Michele Graciotti may publish in the future.

Co-authorship network of co-authors of Michele Graciotti

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Graciotti. A scholar is included among the top collaborators of Michele Graciotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Graciotti. Michele Graciotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Graciotti, Michele & Lana E. Kandalaft. (2024). Vaccines for cancer prevention: exploring opportunities and navigating challenges. Nature Reviews Drug Discovery. 24(2). 134–150. 11 indexed citations
2.
Graciotti, Michele, Cheryl Lai-Lai Chiang, Philippe Guillaume, et al.. (2023). Cancer vaccines based on whole-tumor lysate or neoepitopes with validated HLA binding outperform those with predicted HLA-binding affinity. iScience. 26(4). 106288–106288. 4 indexed citations
3.
Berti, Cristiana, Michele Graciotti, Alice Boarino, et al.. (2021). Polymer Nanoparticle‐Mediated Delivery of Oxidized Tumor Lysate‐Based Cancer Vaccines. Macromolecular Bioscience. 22(2). e2100356–e2100356. 15 indexed citations
4.
Berti, Cristiana, et al.. (2021). Reduction-Sensitive Protein Nanogels Enhance Uptake of Model and Tumor Lysate Antigens In Vitro by Mouse- and Human-Derived Dendritic Cells. ACS Applied Bio Materials. 4(12). 8291–8300. 6 indexed citations
5.
Graciotti, Michele, Fabio Marino, HuiSong Pak, et al.. (2020). Deciphering the Mechanisms of Improved Immunogenicity of Hypochlorous Acid-Treated Antigens in Anti-Cancer Dendritic Cell-Based Vaccines. Vaccines. 8(2). 271–271. 15 indexed citations
6.
Graciotti, Michele, et al.. (2020). Electroporation as a method of choice to generate genetically modified dendritic cell cancer vaccines. Current Opinion in Biotechnology. 65. 142–155. 12 indexed citations
7.
Harari, Alexandre, Michele Graciotti, Michal Bassani‐Sternberg, & Lana E. Kandalaft. (2020). Antitumour dendritic cell vaccination in a priming and boosting approach. Nature Reviews Drug Discovery. 19(9). 635–652. 219 indexed citations
8.
Lluesma, Silvia Martin, Michele Graciotti, Alizée J Grimm, et al.. (2020). Are dendritic cells the most appropriate therapeutic vaccine for patients with ovarian cancer?. Current Opinion in Biotechnology. 65. 190–196. 13 indexed citations
9.
Mookerjee, Ananda, Michele Graciotti, & Lana E. Kandalaft. (2019). IL-15 and a Two-Step Maturation Process Improve Bone Marrow-Derived Dendritic Cell Cancer Vaccine. Cancers. 11(1). 40–40. 6 indexed citations
11.
Lluesma, Silvia Martin, Michele Graciotti, Cheryl Lai-Lai Chiang, & Lana E. Kandalaft. (2018). Does the Immunocompetent Status of Cancer Patients Have an Impact on Therapeutic DC Vaccination Strategies?. Vaccines. 6(4). 79–79. 7 indexed citations
12.
Graciotti, Michele, Cristiana Berti, Harm‐Anton Klok, & Lana E. Kandalaft. (2017). The era of bioengineering: how will this affect the next generation of cancer immunotherapy?. Journal of Translational Medicine. 15(1). 142–142. 18 indexed citations
13.
Graciotti, Michele, Zhou Fang, Kai Johnsson, & Pierre Gönczy. (2016). Chemical Genetic Screen Identifies Natural Products that Modulate Centriole Number. ChemBioChem. 17(21). 2063–2074. 3 indexed citations
14.
Graciotti, Michele, Mahmood M. Alam, Lev Solyakov, et al.. (2014). Malaria Protein Kinase CK2 (PfCK2) Shows Novel Mechanisms of Regulation. PLoS ONE. 9(3). e85391–e85391. 11 indexed citations
15.
Saladino, Raffaele, Veronica Neri, Claudia Crestini, et al.. (2010). The Role of the Formamide/Zirconia System in the Synthesis of Nucleobases and Biogenic Carboxylic Acid Derivatives. Journal of Molecular Evolution. 71(2). 100–110. 28 indexed citations
16.
Saladino, Raffaele, Veronica Neri, Claudia Crestini, et al.. (2008). Synthesis and Degradation of Nucleic Acid Components by Formamide and Iron Sulfur Minerals. Journal of the American Chemical Society. 130(46). 15512–15518. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026